Salve Therapeutics
Salve Therapeutics is a biotech company revolutionizing gene therapy development by leveraging computational drug discovery to create virtual prototypes of viral-based gene therapy drug candidates. Their platform accelerates R&D, reduces costs, and improves safety for small and medium-sized biotech companies by replacing traditional trial-and-error wet lab experiments with data-driven precision. Salve's AI-driven technology enables faster identification of promising candidates, safer research environments, and scalable licensing partnerships, positioning the company strongly in the growing gene therapy market projected to exceed $20 billion by 2030.
Salve Therapeutics
Salve Therapeutics is a biotech company revolutionizing gene therapy development by leveraging computational drug discovery to create virtual prototypes of viral-based gene therapy drug candidates. Their platform accelerates R&D, reduces costs, and improves safety for small and medium-sized biotech companies by replacing traditional trial-and-error wet lab experiments with data-driven precision. Salve's AI-driven technology enables faster identification of promising candidates, safer research environments, and scalable licensing partnerships, positioning the company strongly in the growing gene therapy market projected to exceed $20 billion by 2030.